RELAFEN
Live / Registered — Registered — Section 8 accepted (as of 04 Oct 2025)
What this means for you
Registered since 05 May 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87702292
- Registration number
- 6048100
- Mark type
- Stylized text
- Filed
- 29 Nov 2017
- Published for opposition
- 10 Apr 2018
- Registered
- 05 May 2020
- Attorney of record
- Joseph I. Hirsch
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammation and pain, particularly with respect to the treatment of rheumatoid arthritis and osteoarthritis
Owner
- Argent Development Group, LLC, Mountain View, CA, US
- Argent Development Group, LLC, Mountain View, CA, US
- Argent Development Group, LLC, Mountain View, CA, US
Prosecution history
- 04 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 04 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 04 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 04 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 04 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Jun 2025 — TEAS SECTION 8 RECEIVED
- 05 May 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 May 2020 — REGISTERED-PRINCIPAL REGISTER
- 01 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Mar 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Mar 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Mar 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Mar 2020 — ASSIGNED TO LIE
- 05 Mar 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Feb 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED